Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.
A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.
A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.
A misdiagnosed case between primary biliary cholangitis and mild adult idiopathic ductopenia shows why obtaining a second medical opinion is essential in biliary duct disorders.
Frequent snoring is linked to a higher risk of fatty liver disease, independent of obesity or diabetes, underscoring the role of proper sleep in liver health.
Coffee consumption, due to caffeine, has psychoactive properties and health benefits, improving cognitive function and reducing disease risk, however, excessive intake can be harmful.
Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.
Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.
15 de November de 2018
30 de June de 2021
30 de January de 2023